Investors & Media
VYNE Therapeutics™ is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
2.57
Mar. 23, 2023 10:17:22- Change 0.04 (1.581%)
- Volume 2,204
- Today's Open 2.6
- Previous Close 2.53
- Today's High 2.6
- Today's Low 2.57
- 52 Week High 14.22
- 52 Week Low 1.998